4CPS-159 Quality of life assessment and efficacy of secukinumab in plaque psoriasis disease

BACKGROUND: Secukinumab has demonstrated efficacy in moderate to severe plaque psoriasis (PP) by improving the Psoriasis Area and Severity Index (PASI), but patients’ quality of life is not always quantified in clinical trials. PURPOSE: To evaluate the efficacy of secukinumab in PP treatment and how...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hosp Pharm
Main Authors: Ruiz, M Pedrosa, Carmona, I Moya, Yañez, E Sanchez, Ovies, JM Fernandez
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Group 2018
Fag:
Section 4: Clinical pharmacy services
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535509/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.250
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker